At Amzak Health we invest in first-in-class, best-in-class technologies in biotech and medtech.
Employees: 1-10
Investment Stage: Series B
Portfolio 18
| Date | Name | Website | Total Raised | Location |
| 13.02.2025 | Sound Blad... | soundblademedical.com | $16.5M | - |
| 03.01.2025 | Histosonic... | histosonics.com | $314M | United Sta... |
| 10.03.2024 | Synergy Sp... | synergyspinesolutions.com | $30M | United Sta... |
| 10.03.2024 | KOKO Medic... | kokomed.com | - | - |
| 04.11.2023 | Gynesonics... | gynesonics.com | $277.7M | United Sta... |
| 24.09.2020 | Monte Rosa... | monterosatx.com | $445.5M | United Sta... |
| - | Reneo Phar... | reneopharma.com | $145M | United Sta... |
| - | Teleflex | teleflex.com | $18.5M | United Sta... |
| - | Neuros Med... | neurosmedical.com | $144.5M | United Sta... |
| - | Contego Me... | contegomedical.com | $43.3M | United Sta... |
Show more
News 44
Show more
Mentions in press and media 6
| Date | Title | Description |
| 16.09.2025 | ShiraTronics Announces Positive 12-Month Follow-Up Results from RELIEV-CM Pilot Study, Demonstrating Sustained Clinical Benefit with Investigational Implantable Neuromodulation Therapy for Chronic Mig... | MINNEAPOLIS, Sept. 16, 2025 /PRNewswire/ -- ShiraTronics, Inc., a clinical-stage medical device company focused on developing novel neuromodulation therapies for chronic migraine, today announced compelling 12-month follow-up data from its ... |
| 15.10.2024 | ShiraTronics: A New Dawn for Chronic Migraine Sufferers | Chronic migraines are like shadows that loom over millions, darkening their days and stealing their joy. For those who suffer, the search for relief can feel like an endless journey through a fog. Enter ShiraTronics, a beacon of hope in thi... |
| 09.10.2024 | ShiraTronics Raises $66 Million in Oversubscribed Series B Financing to Advance Pioneering Treatment for Chronic Migraine | Implantable Neuromodulation System Shows Early Promise in Improving Patient Quality of Life by Reducing Monthly Headache Days and Severity of Migraine Attacks MINNEAPOLIS, Oct. 9, 2024 /PRNewswire/ -- ShiraTronics, a clinical-stage medical ... |
| 21.08.2024 | HistoSonics: A New Dawn in Non-Invasive Cancer Treatment | In the world of medical technology, innovation is the lifeblood that fuels progress. HistoSonics, a pioneer in non-invasive cancer treatment, has recently secured $102 million in Series D funding. This investment is not just a financial boo... |
| 20.08.2024 | HistoSonics: $102 Million (Series D) Raised To Scale Non-Invasive Histotripsy Platform | HistoSonics, a manufacturer of the Edison Histotripsy System and novel histotripsy therapy platforms, announced the completion of an oversubscribed $102 million Series D financing. This funding round was led by Alpha Wave Ventures, a world ... |
| 15.08.2024 | HistoSonics Secures $102M to Advance Non-Invasive Liver Tumor Treatment | What You Should Know: – HistoSonics, a medical technology company specializing in histotripsy, a non-invasive treatment for liver tumors raises $102M in Series D financing round. – Led by Alpha Wave Ventures, with participation from new inv... |